Psychiatr. praxi. 2014;15(1):6-8
The most frequent reasons for hospitalization in patients suffering from schizophrenia are relapses and pharmacoresistancy. The main
cause of relapse is nonadherence which can be partially managed by depot antipsychotics. The gold standard of treatment in pharmacoresistant
patients is clozapine. In spite of this clozapine is initiated late in clinical practice and before initiating clozapine, antipsychotic
polypharmacy is very common. After the failure of clozapine monotherapy there are several possibilities including combination
of clozapine with other antipsychotics and clozapine augmentation. There are very few controlled studies supporting these strategies
with inconsistent results; therefore the pseudoresistance should be eliminated. The optimal possibility includes clozapine plasma levels
assessment. The results obtained at department of psychiatry in Brno show, that in patients non-responding to clozapine its plasma
levels are surprisingly often out of the therapeutic range. The clozapine plasma levels assessment in these problematic patients helps
to choose the further optimal treatment strategy.
Published: March 1, 2014 Show citation